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The methods most commonly used for the detection of antiviral 
bodies in the sera of animals immune to the virus of equine encephalo- 
myelitis have consisted of the injection of serum-virus mixtures intra- 
cerebrally into mice or guinea pigs.  In this way it has been found 
that the protective power of serum was always of a low order in spite 
of the fact that a solid resistance was displayed by laboratory animals 
when tested intracerebrally or by horses convalescent from the disease. 
Reports of the demonstration of antiviral substance by intracerebral technique 
have already been discussed (1).  Experiments indicated that guinea pigs later 
shown to be immune to intracerebral injection of 1,000 minimal infective doses 
had sera which protected mice only against 1 to 10 doses or not at all.  Using  a 
method which was not quantitative, Howitt (2) found that guinea pigs immune 
to an intracerebral test for immunity could be shown to have protective anti- 
bodies in their sera only irregularly.  Furthermore, these antibodies disappeared 
more rapidly than the observed immunity.  Horses  which have recovered from 
natural  infection are immune to subsequent attacks  but the demonstration of 
protective antibodies in their sere has been difficult and has usually resulted in 
failure (3-6).  TenBroeck  and Merrill (7), however, determined that in guinea 
pig tests antiviral bodies were revealed when serum of convalescent horses was 
added to low multiples of minimal cerebral infective doses of virus.  They have 
later resorted to another method of testing with more success, namely, guinea 
pig pad inoculation of serum-virus mixtures.  1 
In the study of certain other viruses, it has been shown that the 
demonstration of protective antibodies in the sera of immune animals 
depends to a large extent on the route by which serum-virus mixtures 
1  TenBroeck, C., personal communication. 
173 174  virus oF EQUINE ENCEPHALOMYELITIS.  I 
are inoculated into test animals.  Variations in the degree of protec- 
tion  afforded by  antiserum in different  sites  in  the  same  species  of 
animal are of importance in studies of the mechanism of the immune 
reactions in certain virus diseases.  This matter will be discussed later 
but the findings described in this paper provide, among other results, 
TABLE  I 
Prior Observations in Which the Protective Power of Serum in a Serum-Virus Mixture 
Varied in the Same Host with the Route of Inoculation 
Route of injection  Route  of injection 
Investigator  Virus used  #mimal  injected  resulting  in  resulting  in less  or no 
protection  protection 
Kanteufel (8) 
todd (9)  .. 
~Iallauer  (10) 
Indrewes (11) 
2raigie and Tulloch 
(12) .... 
?airbrother  (13)... 
~abin (14) .... 
~oyal (15). 
~ndrewes (11) .... 
3abin (14, 16). 
~abin (14) 
~abin (14) 
Francis and Magill 
(17). 
Findlay (18) 
Fowl pox 
"  plague 
Vacciuia 
Virus III 
B virus 
Pseudorabies 
Herpes 
Rift  Valley 
fever 
Chickens 
Rabbits 
c~ 
c~ 
Guinea pigs 
Rabbits 
Mice 
cc 
Subcutaneous 
Intramuscular 
Intradermal 
c~ 
~c 
Intracerebral 
Intradermal 
cC 
Intranasal, sub- 
cutaneous 
Intradermal 
Intraperitoneal 
On the comb 
Intravenous 
Intracerebral,  in- 
tratesficular, 
intravenous 
Intratesticular 
Intracerebral 
Into the anterior 
chamber of the 
eye 
Intratesticular, 
intravenous 
Intracerebral 
i 
Intranasal 
still another example of such variation.  Table I  summarizes most of 
the  earlier  reports  in  which differences  in protective  power of serum 
depended  on the  route of inoculation. 
The  record  indicates  clearly  that  with  one  possible  exception,  the 
procedure of intracerebral  testing yields poorer results for the demon- 
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In experimental equine encephalomyelitis there were definite indica- 
tions that young mice would be infected by intraperitoneal inoculation 
of virus and consequently that serum protection tests might be per- 
formed by this route. 
Mice less than 14 days of age have been found to be susceptible to intraperi- 
toneal inoculation of the Western strain of this virus (19), and more recently it 
has been shown (20)  that this animal, at the age of from 12 to 15 days, is prac- 
tically invariably susceptible to both Eastern and Western strains, and even with 
high dilutions of virus.  Although experiments by MerriU (21)  with mixtures of 
serum and virus were designed for a purpose other than that under investigation 
now, and were performed in a  manner different from those usually planned for 
the demonstration of the titre of antibody content of a  serum,  they leave the 
impression that a  greater degree of protection was afforded when the intraperi- 
toneal route rather than the intracerebral was used for inoculation of mice.  In 
the  use  of  serum  tests  for an  epidemiological  study,  TenBroeck,  Hurst,  and 
Traub (22) stated in a footnote to a table that while most of their tests were done 
by intracerebral injections, they have since found the intraperitoneal route more 
satisfactory.  No further reference to this finding was made by them. 
In view of the fact that the usual intracerebral test for detection of 
serum antibody yielded little or no antiviral substance in spite of a high 
degree of resistance to virus injection (1),  the question arose as to 
whether the weak humoral antibody content was to be regarded as 
absolute or whether the antiviral substance was not readily detectable 
by means of this  method.  Furthermore, one of the  studies under 
investigation concerned a  comparison of infectivity by intracerebral 
and  intraperitoneal  routes  simultaneously  with  relative  effect  of 
serum, since prior to the work of Sabin (14), it was thought that the 
reason it was more difficult to  demonstrate antibody by a  certain 
route was because that route was a more sensitive indicator for the 
presence of virus.  The mechanism governing the variations found 
by the two routes in the relative protective power of immune sera will 
be discussed, however, in a forthcoming paper. 
Methods and Materials 
Virus.--The  Eastern strain of the virus was used in most of the experiments 
but the Western strain was also tried.  The strains were the same as those em- 
ployed in previous work in this  laboratory  (23)  and have been maintained  by 
intracerebral passage in mice with storage in 50 per cent buffered glycerol.  In 176  VIRUS  OF  EQUINE  ENCEPHALOMYELITIS.  I 
these experiments only fresh virus was used, that is, none but the brains of mice 
prostrate with the disease or recently succumbed to it.  Such brains were fre- 
quently kept whole in the refrigerator for several hours but were always used the 
same day.  They were ground with alundum and enough broth to make a  20 
per cent suspension; for example, two mouse brains weighing 0.8 gin. were ground 
with 4 cc. of broth.  After centrifugation of about 2,000 ~.P.~. for 2 or 3 minutes 
to deposit the larger particles, serial tenfold dilutions in broth were made from 
the supernatant.  Dilutions were then 2  ×  10  -1, 2  ×  10  -~, etc.  A fresh pipette 
was used for each dilution. 
Sera.--Hyperimmune  rabbit  serum  was  obtained  from  rabbits  which  had 
received subcutaneous injections of  10 per cent suspensions of  infected mouse 
brains in doses of 2, 4, 5, and 11 cc. at intervals of 5 to 7 days.  They were bled  2 
10 days after the last dose and then at 2 to 4 day intervals.  All specimens were 
pooled.  Hyperimmune guinea pig serum consisted of pooled sera.  They were 
derived from guinea pigs immunized with mouse brain virus followed by a  test 
for immunity and further subcutaneous doses  of active mouse brain virus. 
Hyperimmune mouse serum was obtained from old mice which received intra- 
peritoneal or intramuscular injections of mouse brain virus followed by an intra- 
cerebral test for immunity.  13 days later they were bled from the heart and 
the survivors bled every day or so until all were dead.  These specimens were 
all pooled. 
The serum used with the Western strain of the virus was from a  rabbit that 
was given 2.5 cc. of a 2 per cent suspension of mouse brain virus subcutaneously 
and 5 cc. of a  10 per cent suspension 4 months later.  It was bled for serum 9 
months after that. 
Five horse sera  3 were from animals in areas in New Jersey in which equine 
encephalomyelitis occurs, but there was no history of disease or inoculations of 
serum or vaccines in any of them.  Eight horse sera  3 were from animals in Vir- 
ginia and they had either recovered from the disease or had been in contact with 
known cases.  Most  of  these  sera  were passed  through  Seitz filters  to  insure 
sterility. 
All sera were stored in the refrigerator without preservative. 
Serum-Virus Mixtures.---0.5 cc. of the dilution of virus was added to 0.5 cc. 
of undiluted serum and mixture brought about by shaking.  Thus a  dilution of 
2  ×  10  -s of virus added to an equal amount of undiluted serum gave a  final 
dilution of virus of  10  -~.  Virus was  mixed with normal serum first and then 
with immune serum and the lower dilutions of virus were added to the sera before 
the higher.  The mixtures were injected without incubation except as noted. 
Mice.--All of those used were of the Rockefeller Institute albino strain.  Mix- 
2 Operations on animals were performed with the aid of ether anesthesia. 
We wish to thank Dr. Carl TenBroeck and Dr. H. C. Givens for their coopera- 
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tures were injected  intraperitoneally  into infant mice.  Their ages varied from 
12 to 15 days and in one instance  16 days, but in the usual experiment  all mice 
born on the same day were used.  This particular age of mice was selected because 
studies  of Sabin  and Olitsky  (20) indicated  that some resistance  to inoculation 
by the intraperitoneal  route begins  to appear even  at 21  to 30 days.  Regular 
results  in  this  test  depend  upon  taking  into  consideration  the  appearance  of 
resistance  at different  ages in different mice.  As will be noted, in some experi- 
ments mice born on 2 or 3 successive days but never more than 3 were employed. 
These  young mice usually  averaged  in  weight  between  7 and 9 gin.  but larger 
and smaller ones were encountered.  Intracerebral injections were given to adult 
mice  except  as  noted.  Their ages  are  indicated.  The dose  by the  intraperi- 
toneal route was 0.1 cc. except as noted and the intracerebral  dose was 0.03 cc. 
Intraperitoneal injections  were made before  intracerebral;  immune  serum-virus 
mixtures  were injected  before normal,  and higher dilutions before lower.  Both 
intraperitoneal  and  intracerebral  inoculations  of  any  particular  dilution  were 
made from the same tube. 
Record and Estimation of Results.--The incubation  period  in the lower dilu- 
tions  by either  route was usually 2 days.  Each day from then on, fewer mice 
developed  the disease  and by the 5th day practically all  mice still living  con- 
tinued to live.  Rarely one would die after that so that all animals were kept for 
10 days after inoculation but most at least a week longer.  Mice were considered 
to have developed  encephalitis  if  they were found dead,  completely  prostrate, 
or in a state of generalized convulsions.  Milder degrees of illness were observed 
further until such  evidence developed,  However,  no mouse presenting  definite 
signs  of  the  disease  has  been  observed  by us  to  recover.  Occasionally  when 
there was doubt as to whether a mouse died of the disease, its brain was ground 
and injected  into other mice to test for virus. 
For convenience of designation,  it was assumed that in the highest  dilution  in 
which more than half the number of the mice developed encephalitis one minimal 
infective dose of virus  was present.  In each test separate  controls were included 
with  normal  serum  for each  route  of inoculation,  and  results  were considered 
only in comparison with  them. 
Relative Protection Obtained by Intracerebral and [ntraperitoneal Methods 
ttyperimmune Serum.--In the first series of experiments the relative 
protective power of hyperimmune sera derived from guinea pigs, mice, 
and  rabbits  was  determined  by  the  respective  intraperitoneal  and 
intracerebral  injection  of  serum-virus  mixtures.  Previous  intra- 
cerebral tests  (1)  had shown that hyperimmune serum had  10 to  100 
times as much antibody, as a  rule,  as immune serum; that is,  it pro- 
tected  against  10  to  100 minimal  intracerebral  doses of virus.  The 
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Examination  of Table II  shows that  all of the  hyperimmune sera 
protected  against  a  very  much  larger  number  of  minimal  infective 
TABLE  II 
Relative Protective Power of Sera in Serum-Virus Mixtures Inoculated  by 
Intraperitoneal  and Intracerebral Routes* 
tis  Minimal infective  doses 
of  virus  against  which 
the serum protected 
Intraperi-  Intracere- 
meal doses  bral doses 
10,000 
Control 
100 
Control 
,000,000 
Control 
1,000 
Control 
I00,000 
Control 
100 
Control 
lO,O00l 
Control  t 
Control 
-  indicates not tested; HGP, hyperimmune guinea pig serum; NGP, normal 
guinea pig serum; HM, hyperimmune mouse serum; NM, normal mouse serum; 
HR, hyperimmune rabbit serum; NR, normal rabbit  serum;  ip, intraperitoneal; 
ic, intracerebral. 
* Most  of  the  experiments have been  done  with  adult  mice for the  intra- 
cerebral injections and infant mice for the intraperitoneal.  The reason for this 
was that enough young mice for all could usually not be obtained on a  single 
day.  The  test  recorded  in  Table III shows,  however,  that  the  use  of  adult 
mice for the intracerebral tests did not account for the results obtained. 
doses  of  virus  when  the  serum-virus  mixtures  were  given  by  the 
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cerebral route.  Thus the hyperimmune sera protected against 10 to 
1,000  minimal cerebral doses as compared with  10,00o  to  1,000,000 
infective  units  by  the  intraperitoneal  route.  In  other  words,  the 
protective power by the peritoneal route was from 100 to 1,000 times 
that  by  the  cerebral.  Furthermore,  certain  serum-virus  mixtures 
which resulted in infection  when injected intracerebrally  were innocuous 
intraperitoneally. 
As noted in Table I, Findlay (18)  confirmed the finding of Francis 
and Magill (17) that mixtures of immune serum and Rift Valley fever 
virus produced infection when inoculated intranasally into mice but 
not  when  given  by  the  intraperitoneal  route.  However,  Findlay 
found that this difference between the intranasal and intraperitoneal 
routes depended on the amount of the inoculum. 
Findlay used an  intranasal dose of 0.03  cc.  and an intraperitoneal dose of 
0.4 cc. and found the mice inoculated with the  latter remained well.  However, 
when the intranasal dose was kept at 0.03  cc. and the intraperitoneal dose was 
also 0.03 cc., no difference between the protective power of the serum by the two 
routes could be detected. 
Because of this, the question arose as to whether similar variation 
in  the dose intraperitoneally and intracerebrally in our experiments 
could account for the difference in the protective power of the serum 
by the two routes.  Accordingly, an experiment was planned to test 
this.  It was done exactly as those in Table II, except that all the mice 
were 15 days old; intraperitoneal dose was 0.03  cc;, and intracerebral 
dose was 0.03 cc.  Table III shows the result. 
This  experiment  indicated  that  the  difference in  the  protective 
power of a serum when serum-virus mixtures were given by these two 
routes did not depend on the amount of the inoculum nor on the age of 
mice  receiving intracerebral  injections.  In  fact,  in  this  series  the 
peripheral inoculation yielded 10,000 times the protective power of the 
central.  Another trial with mice of the same age with similar outcome 
appears in Experiment 4 (Table II). 
The  Value of Incubation o/Serum-Virus Mixtures  before Inocula- 
tion.--The purpose  of  the  following experiments was  to  determine 
whether incubation had any effect on increasing the amount of virus 
against which the sera could protect when incubated mixtures were 
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incubation would eliminate the difference in protective power observed 
when  unincubated  mixtures were given by the  two  different  routes. 
There is an extensive record of  attempts to disclose  the influence  of incuba- 
tion on the action of antisera on viruses, although most workers agree  that cer- 
tain protective power can be secured without incubation being applied  to serum- 
virus mixtures.  Yet  the question is important from the viewpoint of practical 
procedure since  some viruses deteriorate at  incubation  temperature.  Further- 
more, if keeping mixtures at 37°C. could be shown  to increase  the action of the 
contained serum beyond the inactivating effect of that temperature on the virus, 
some evidence for an in vitro interaction between it and virus might be supposed 
to have taken place, 
TABLE  III 
Inoculation of the Same Dose of Serum-Virus Mixtures by Intracerebral and 
Intraperitoneal Routes 
l~oute 
of in- 
jection 
ip 
ic 
Minimal infective  doses 
Number of mice developing encephalitis of three injected  of  virus against which 
;erum  ~  __  the serum protected 
10-1  I0-~  10-3  10-4  10-~  10-6  10-7  10-8  10"-9 toIntr~dP%'ises  ~nt~adCosere  ~ 
HR  3  0  0  0  0  ....  100,000  I 
NRI-I-I-t-J  s  3  3  7  2  1  ll-lControl  t 
HR  --  --  3  3  2  0  --  --  --  10 
Abbreviations as in Table II.  Eastern strain of virus. 
Employing a  method  that  was  not  quantitative,  and  the  virus  of  equine 
encephalomyelitis, Howitt (5) studied the effect of incubation for varying periods. 
The results, however, showed no effect.  Cox and Olitsky (1) reported that with 
the same virus incubation of serum-virus mixtures for 2½ hours at 37°C. increased 
the number of intracerebral infective units against which a serum could protect. 
Finally,  the  work  of  Merrill  (21) with  this  virus  indicated  some  interaction 
in vitro between the infective agent and the immune serum.  Table IV records 
the results of experiments on the effect of incubation. 
The  tests  revealed that  the protective  capacity of the  serum was 
not  affected  by  the  incubation  of  serum-virus  mixtures  when  they 
were done in this way.  As a corollary, it is piain that the difference in 
degree of protective power of unincubated mixtures exhibited by the 
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Sera  from Normal Horses Derived  from Epizootic Zones.--The results 
thus far described were obtained entirely with sera of hyperimmunized 
laboratory animals.  Because of the  striking difference in  the  two 
routes in the demonstration of protective antibody, it was now desired 
to  determine whether  the  superiority of  the  intraperitoneal route 
applied to tests with horse sera and whether such procedures might be 
of value in epidemiological  studies. 
There were available  for  study the  sera from five  horses which 
came from districts in New Jersey where cases of equine encephalo- 
TABLE  IV 
Effect of Incubation for 2½ Hours at 37°C. on the Protective Power of Serum When 
Serum-Virus Mixtures Were Given by the Intraperitoneal  Route 
gxperi-  Age of 
ment  mice 
No. 
days 
1  14-16 
2  14-16 
Incubation 
None 
2½ hrs. 
None 
2½  hrs. 
Serum 
HR 
NR 
HR 
NR 
HR 
NR 
HR 
NR 
Number of mice developing encephalitis of three 
injected 
lO-i 
1 
2 
2 
10-2  10-S 
1  0 
0  0 
1  0 
0  0 
10-4  10-6 
0  0 
3 
10-6  10-7 
2 
0 
3 
3  2 
10-8  10-9 
0 
0 
2  - 
3 
Minimal in- 
fective intra- 
peritoneal 
closes of virus 
against which 
the serum 
protected 
100,00G 
Control 
100,00~ 
Control 
1,000,00C 
Control 
1,000,0013 
Control 
Abbreviations as in Table II.  Eastern strain of virus. 
myelitis have occurred.  They had no clinical evidence of the disease 
and had not received any injections of virus, vaccines, or antiserum. 
The  five  sera  had  been  previously  tested  for  antiviral substance  by  Dr. 
TenBroeck and his  associates;  three  were  found positive and  two,  Nos.  0815 
and 0806,  negative.  Because of the possibility that protective capacity might 
be detected in the latter two by the use of the intraperitoneal technique, addi- 
tional controls of broth, normal rabbit serum, or normal guinea pig serum were 
used.  Table V shows  the results of trials with these horse sera. 
From Table V it will be noted that with broth or normal rabbit serum used 
as a  control, serum 0815,  previously designated as  negative, protected against 182  VIRUS  0~"  EQUINE  ENCEPHALOMYELITIS.  I 
10 to 100 minimal intraperitoneal infective doses and against 1 to 10 intracerebral 
units of virus.  This result suggested that  specific antibody might be present in 
small amounts.  With  normal  guinea  pig  serum  as  a  control,  serum  0806,  the 
other "negative" sample, protected against possibly one intraperitoneal or intra- 
TABLE  V 
Protective Power of Horse Sera  (New Jersey Series) When Serum-Virus Mixtures 
Were Inoculated by the Intraperitoneal and Intracerebral Routes 
i 
~g 
1  ip 
tt 
,t 
ic 
!- 
I 
2  iip 
ic 
j  - 
3  ip 
ic 
t, 
Number of mice developing  encephalitis of three  Minimal  infective  doses 
injected  of virus against which 
Ao~  e  Serum  the serum protected 
mice 
I0-I  i0-~  10-S  10-4  i0-~  10"6 10"7  lO-S  lore  .l_n_tral~e_r!- In_truer e- 
days 
!14-15  0819  --  3  2  1 
14-15  0815 
14-15  Broth 
25+  0819  2~ 
25+  0815 
14-15  0692  3  2  0  1 
14-15  0815  2 
14-15  NR 
214-  0692  3 
21~  0815 
15  0814  3  1  0  0 
15  0806 
15  NGP 
234-  0814 
234-  0806 
234-  NGP 
i  2  2 
I  3 
I 
I 
0  0  0  -  - 
2  1  1  0  - 
3  3  2  1  - 
2  0  0  0  0 
2  ]  2  0  0 
0  -1 
2  1  !  0  0  -- 
3  2  2  2  - 
3  31  1 
3  3  2  0  - 
0 
i- 
3  2  2  0  i-- 
3  3  2  2  -- 
311  0  --i-- 
3  ~3  3  0  -- 
I  3  3  2  1 
Intraperi- 
toneal doses[ brnl doses 
Control? 
Control 
$ 
Control ? 
Control ? 
Control 
Control? 
100,00(] 
to 
1,000,00C 
Control 
It 
10 to 100 
Control 
Abbreviations as in Table II. 
* Amount of virus against which serum protected is explained in the text. 
t  One died of the inoculation. 
cerebral  infective dose  of  virus.  Hence  serum  0806  was  regarded  as  a  more 
satisfactory  control  than  serum  0815.  The  data  of  Table  V  were  therefore 
evaluated on the basis of serum 0806, broth,  normal rabbit  and guinea pig sera 
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Viewed in this way, the results showed that sera 0819,  0692,  and 
0814,  previously called positive by  Dr.  TenBroeck,  contained  pro- 
tective  antibodies,  and  0814  protected  against  a  larger  number  of 
infective  doses  of  virus  when  given  intraperitoneally  than  intra- 
cerebrally.  The latter sample rendered from 10 to 100 units of virus 
non-infective by the intracerebral test and 100,000 to 1,000,000 by the 
intraperitoneal method. 
The supply of serum 0806 was soon exhausted; a horse serum was therefore 
sought which showed no protective power by this intraperitoneal technique for 
use as control in further experiments. 
Horse M 33 had been immunized with meningococci  and bled for serum on 
Oct. 7, 1919.  This serum was sealed and stored in the refrigerator in this labora- 
tory until Feb. 7, 1938.  On the latter date a portion of it was passed through 
a Seitz filter.  An electrometric  determination of pH was 7.8 and cultures yielded 
no growth of bacteria so that it was believed not to have essentially  deteriorated. 
The serum M 33 was then tested in comparison  with normal guinea pig serum 
as recorded in Experiment 1 of Table VI.  The outcome was a difference  in titre 
of only one minimal intraperitoneal infective dose (as with serum 0806) and since 
this was not significant in respect to the number of animals employed with each 
dilution, it was decided to use M 33 as a control for further tests with horse sera. 
Sera from Horses Recovered from, or Exposed by Contact to Equine 
Eneephalomyelitis.--The  next series of tests were performed on sera 
obtained from four horses that had shown clinical signs and recovered 
from equine encephalomyelitis, and four others known to have been 
in contact with one to four horses having signs of the malady.  All the 
animals were from epizootic areas in Virginia and the sera were col- 
lected from 6 months to 4 years after recovery from or contact with 
the disease.  Six separate experiments were undertaken and these are 
recorded in Table VI. 
In Table VI it can be seen that sera  1 and 5 protected against a 
larger amount of virus intraperitoneally than intracerebrally; in the 
instance of serum 1, 100,000 times as much.  Experiments 3, 4, and 5 
were not planned to determine the amount of virus against which a 
serum protected but to show whether the existence of antibody could 
be detected with a set dose, so as to give a practical aspect to the intra- 
peritoneal test (Experiment 4).  In this way, every one of the sera of 
horses known to have recovered from equine encephalomyelitis showed 184  VIRUS  OF  EQUINE  ENCEPI{ALOMYELITIS.  I 
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power to protect against the virus.  Furthermore, the serum of one 
horse which did not have any illness that was recognized but had been 
in contact with the disease also gave evidence of specific antibody. 
The results of the tests with horse sera  show the intraperitoneal 
route to be more sensitive than the intracerebral (0814,  1, and 5) and 
also that the intraperitoneal technique would probably be a valuable 
tool for epidemiological studies since all of the sera of horses known to 
have had the disease gave strongly positive reactions (1, 3, 4, and 6) 
and sera of others (four of nine) not known to have shown clinical 
signs but which have been in contact with the disease also contained 
measurable, definite antibody (0819, 0692, 0814,  and 5). 
DISCUSSION 
The method ordinarily employed heretofore for the recognition and 
measurement of humoral antibody in  equine encephalomyelitis has 
consisted of the injection of serum-virus mixtures into the brains of 
mice.  The present experiments show that the intraperitoneal route 
is more sensitive for this purpose.  The basis for this is to be found in 
the uniform susceptibility of 12 to 15 day old mice to the intraperito- 
neai injection of the virus  (20).  In most instances there is only a 
tenfold or  no  difference between  intracerebral  and  intraperitoneal 
titers; 12 to 15 day old mice are approximately equally susceptible to 
inoculation by the two routes. 
The intraperitoneal procedure has been shown to be applicable not 
only to the sera of laboratory animals immunized with active virus but 
also to the sera of horses naturally infected, or of those exposed by 
contact to the disease.  It should be of value not only because of its 
ability to detect antibody to  a  much higher degree than the intra- 
cerebral method, but also,  in  view of the sensitiveness of the  test, 
because  of  its  capacity  to  indicate  negative  findings with  greater 
assurance that antibody is not at all present. 
The results of the application of this test to horse sera do not permit 
general conclusions because of the small number of specimens exam- 
ined.  Nevertheless, they furnish some indication that horses recov- 
ered from the disease have serum antibodies regularly and that these 
may persist for at least 4 years.  In addition, antibodies may be found 
in the sera of horses that have shown no signs of the disease but that PETER K. 0LITSKY AND CARL G. HARFORD  187 
live on farms where the infection has been prevalent, while others from 
such farms may be negative.  That  the  sera  of horses not having 
dinically apparent disease may contain antiviral substance has already 
been found by TenBroeck, Hurst, and Traub (22) and confirmed by 
Giltner and Shahan  (6).  A  more extensive investigation on larger 
numbers of animals exposed by contact is necessary before one can say 
whether the intraperitoneal method can disclose a higher percentage of 
positive reactions for antibody than the intracerebral or other methods. 
In prior reports in which animals were described as solidly immune 
to  equine encephalomyelitis, it has been stated that this immunity 
was associated with a m~nimal amount of protective antibody in the 
serum.  The present experiments show that perhaps the discrepancy 
between the amounts of immunity and antibody can be explained by 
the demonstration of large amounts of antibody by the method of 
intraperitoneal test. 
Certain aspects of the mechanism underlying the phenomenon of 
the superiority of antibody detection by the intraperitoneal test will 
be discussed in a forthcoming paper.  For the present, some remarks 
may be made with regard to the reaction of immune serum and virus 
in vitro. 
It has been mentioned that the work of Merrill (21) indicated some 
kind of interaction in vitro between this virus and serum.  He con- 
eluded from  his  experiments that  combination between  virus  and 
antibody had occurred in vitro probably resulting in aggregation of 
virus particles.  It should be stated that our experiments do not give 
evidence as to whether there is combination in the test tube.  They 
do demonstrate, however, that in the dilutions which show protection 
by the intraperitoneal route and not by the intracerebral, the infec- 
tious activity has not been abolished in vitro by the immune serum; 
in other words, that the immune serum is not directly virucldal by the 
intraperitoneal route.  This is  evident from the fact  that  material 
taken from a given tube may not give rise to infection if injected intra- 
peritoneally but will if inoculated intracerebrally.  If antibody has 
combined with virus in such tubes, the combination must be disso- 
ciable when in contact with certain tissues, inasmuch as protection 
may or may not occur, depending on the tissue into which the serum- 
virus  mixture  is  injected.  That  variation  in  protective  power  of 188  VIRUS OP  EQUINE  ENCEPHALOMYELITIfl.  I 
antiviral serum according to route of inoculation indicates that the 
consummation of the immune reaction is not based on direct inacti- 
vating effect, has  been  suggested before by  several workers among 
whom may be mentioned Andrewes (11), Sabin (14), and Francis and 
Magill  (17). 
Finally to be stressed in this discussion is the point that the behavior 
of serum-virus mixtures, when injected by different routes, is not the 
result of the greater capacity of one route to detect unneutralized virus, 
a  fact first demonstrated by similar quantitative, comparative titra- 
tions for vaccinia, herpes, B virus, and pseudorabies viruses (Sabin, 14). 
SUMMARY AND  CONCLUSIONS 
Young (12 to 15 day old) mice are approximately as susceptible to 
the virus of equine encephalomyelitis, Eastern or Western strain, when 
it is given intraperitoneally as are adult mice when the virus is injected 
intracerebrally.  With this susceptibility by the intraperitoneal route 
as a  basis,  the injection of immune serum-virus mixtures intraperi- 
toneally was found to result in protection in dilutions which give rise 
to infection after intracerebral inoculation. 
The  difference of protective power  by  the  two  indicated routes 
was shown not to depend on the amount of inoculum nor on the age 
of  the  intracerebrally  injected  mice.  Incubation  at  37°C.  for  2½ 
hours neither increases nor diminishes the protective action of im- 
mune serum when the intraperitoneal method is employed. 
The phenomenon  of selective protection in different tissues is elicited 
by the sera of hyperimmunized mice, guinea pigs, and rabbits and by 
sera derived from horses infected with the disease in nature or exposed 
to it by contact.  Of four horses recovered from the malady, all showed 
antibody in  their  sera;  of others exposed by  contact,  four of nine 
animals revealed antiviral bodies, when the intraperitoneal technique 
was employed.  These tests on horse sera have pointed to the poten- 
tial value of this procedure for epidemiological studies. 
Finally, the reaction itself has significance through its bearing on 
the mechanism of immunity. 
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